Gilead’s antiviral is encouraging as coronavirus candidate but isn’t likely to provide long-term shareholder value
February 03, 2020 at 13:49 PM EST
Shares of Gilead Sciences Inc. rallied in afternoon trading on Monday over investor excitement about a coronavirus treatment candidate.
